Psoriasis Archives - Rheumatology Advisor

Like diabetes, moderate alcohol consumption has been found to have a protective effect on autoimmune disorders13 — for example, decreasing a person’s risk of developing hypothyroidism. In addition, research published in Clinical Endocrinology found a link between alcohol consumption and risk reduction for Graves’ disease.14 However, other studies have identified multiple effects that alcohol has on the hypothalmopituitary axis — for example, suppression of thyroid function through cellular toxicity and a decrease in peripheral thyroid hormones.15 In 2015, Alcohol and Alcoholism16 published a study that explored the relationship between the thyroid axis and alcohol-seeking behavior in patients with alcohol dependence. The investigators identified correlations between thyroid stimulating hormone; free triiodothyronine; and the questionnaires used to measure alcohol cravings and anxiety, depression, and aggression, indicating that, if confirmed in larger samples, the thyroid axis “might represent a biomarker of alcohol craving and drinking.”

Spondyloarthritis

Is There an Association Between Psoriasis/PsA and Thyroid Disease?

By

Brandon May

April 19, 2021

Aside from autoimmunity, an analysis of the tie between psoriasis and thyroid diseases is provided.

young woman visiting covid19 vaccination site

Spondyloarthritis

Psoriasis Task Force Recommends First Available COVID-19 Vaccine for Patients With Psoriasis/PsA

By

Kristin Della Volpe

March 19, 2021

Updated guidance suggests possibly pausing methotrexate use for 2 weeks after COVID-19 vaccination in patients with psoriasis or psoriatic arthritis.

Vasculitis

Behçet Disease Associated With Increased Risk for Psoriasis and Psoriatic Arthritis

By

Inga Back, MPH

February 26, 2021

Researchers assessed the association between Behçet disease and psoriasis and psoriatic arthritis, using data from the National Health Insurance Service of Korea.

Clinician examining an MRI scan of the spine

Spondyloarthritis

Axial Disease Improvements Demonstrated With Secukinumab for Psoriatic Arthritis

By

Amit Akirov, MD

January 26, 2021

MAXIMISE trial results demonstrate the safety and efficacy of secukinumab 300 mg and 150 mg treatment for axial disease in people with psoriatic arthritis.

Spondyloarthritis

Low Cardiorespiratory Fitness Linked to Psoriasis, Psoriatic Arthritis

January 26, 2021

Low cardiovascular fitness in late adolescence is associated with an increased risk for incident psoriasis and psoriatic arthritis.

Spondyloarthritis

Increased Risk for Bone Fractures in Patients With Psoriatic Diseases

December 15, 2020

For adults with psoriatic diseases, the likelihood of developing bone fractures is increased.

Spondyloarthritis

Osteoarthritis Risk Higher Among Patients With Psoriatic Arthritis Than Psoriasis Alone

By

Amit Akirov, MD

December 9, 2020

Researchers assessed the risk for osteoarthritis in patients with PsA compared with those with psoriasis and the general population.

Spondyloarthritis

Psoriatic Arthritis and Rheumatoid Arthritis Have Similar Effect on Hand Function

By

Amit Akirov, MD

December 9, 2020

Researchers compared the effect of psoriatic arthritis and rheumatoid arthritis on objective and subjective parameters of hand function.

Meeting Insights

Expert Insights on Psoriatic Arthritis From ACR Convergence 2020

By

Atul A. Deodhar, MD

December 9, 2020

Atul A. Deodhar, MD, provides an insight into the latest research on psoriatic arthritis presented at ACR Convergence 2020.

FDA approves Ocrevus for multiple sclerosis

General Rheumatology

FDA to Review High-Concentration Biosimilar of Adalimumab

By

Brian Park, PharmD

November 30, 2020

The FDA has accepted for review the BLA for AVT02 (Alvotech), a proposed biosimilar to adalimumab; AbbVie, with high concentration (100mg/mL) dosage forms.